← Leaderboards
Richard Schlegel
Georgetown University
$9,837,239
Attributed
$10,412,590
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–15$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$10,412,590 · 8
By mechanism
R01$8,394,066 · 5
R33$1,150,703 · 1
R21$867,821 · 2
Top collaborators
- Anton Wellstein3 shared
Others in their field
Top investigators on “Papillomavirus”
- Ronald T Mitsuyasu · University Of California Los Angeles$106,431,894
- Leonard Freedman · Leidos Biomedical Research, Inc.$53,948,093
- Kathryn M Anastos · Montefiore Medical Center (Bronx, Ny)$50,130,116
- Paula Gonzalez-Maya · Fundacion Inciensa$38,145,031
- David Heimbrook · Leidos Biomedical Research, Inc.$33,306,253
- Paul F Lambert · University Of Wisconsin Madison$31,382,890
Research focus
PapillomavirusLaboratoriesKeratinocyteTumorResearch StudyCellsBiologicalGrantMalignant NeoplasmsGrowth Factor ReceptorsBasePhenotypeHuman TissueResearch PersonnelInfectionFibroblastsMonitorBiologyMalignant Neoplasm Of Cervix UteriSignal PathwayBinding (Molecular Function)In VivoMutantIn Vitro
Grant awards (29)
Conditionally reprogrammed cells as a novel tool for biobanking$378,782
R33 · FY2015 · CA · contact PI
Emerging Papillomaviruses in Immunosuppressed Dogs$412,344
R01 · FY2014 · OD · contact PI
Conditionally reprogrammed cells as a novel tool for biobanking$371,415
R33 · FY2014 · CA · contact PI
Conditionally reprogrammed cells as a novel tool for biobanking$400,506
R33 · FY2013 · CA · contact PI
Emerging Papillomaviruses in Immunosuppressed Dogs$392,140
R01 · FY2013 · OD · contact PI
Emerging Papillomaviruses in Immunosuppressed Dogs$399,501
R01 · FY2012 · OD · contact PI
Emerging Papillomaviruses in Immunosuppressed Dogs$399,393
R01 · FY2011 · RR · contact PI
Biology of the papillomavirus E5 oncoprotein family$395,287
R01 · FY2010 · CA · contact PI
Biology of the papillomavirus E5 oncoprotein family$390,569
R01 · FY2009 · CA · contact PI
Biology of the papillomavirus E5 oncoprotein family$492,122
R01 · FY2008 · CA · contact PI
HPV E6 protein regulation of the hTERT promoter$297,995
R01 · FY2008 · CA · contact PI
Biology of the papillomavirus E5 oncoprotein family$485,884
R01 · FY2007 · CA · contact PI
HPV E6 protein regulation of the hTERT promoter$297,995
R01 · FY2007 · CA · contact PI
A topical treatment for genital papillomavirus infections$179,897
R21 · FY2007 · AI · contact PI
Biology of the papillomavirus E5 oncoprotein family$471,013
R01 · FY2006 · CA · contact PI
HPV E6 protein regulation of the hTERT promoter$306,894
R01 · FY2006 · CA · contact PI
A topical treatment for genital papillomavirus infections$222,324
R21 · FY2006 · AI · contact PI
BIOLOGY OF THE PAPILLOMAVIRUS E5 ONCOPROTEIN FAMILY$484,726
R01 · FY2005 · CA
HPV E6 protein regulation of the hTERT promoter$314,280
R01 · FY2005 · CA
Treatment of Cervical Cancer with Artemisinin$232,800
R21 · FY2005 · AT
HPV E6 protein regulation of the hTERT promoter$25,000
R01 · FY2005 · CA
BIOLOGY OF THE PAPILLOMAVIRUS E5 ONCOPROTEIN FAMILY$470,610
R01 · FY2004 · CA
HPV E6 protein regulation of the hTERT promoter$314,280
R01 · FY2004 · CA
Treatment of Cervical Cancer with Artemisinin$232,800
R21 · FY2004 · AT
BIOLOGY OF THE PAPILLOMAVIRUS E5 ONCOPROTEIN FAMILY$456,902
R01 · FY2003 · CA
BIOLOGY OF THE PAPILLOMAVIRUS E5 ONCOPROTEIN FAMILY$443,594
R01 · FY2002 · CA
BIOLOGY OF THE PAPILLOMAVIRUS E5 ONCOPROTEIN FAMILY$430,672
R01 · FY2001 · CA
PAPILLOMAVIRUS E5 ONCOPROTEIN AND CELL TRANFORMATION$444,476
R01 · FY2000 · CA
ANIMAL ORAL PAPILLOMAVIRUS--MODEL FOR A VACCINE$268,389
R01 · FY2000 · CA